Blood Gas and Electrolyte Analyzer Market Growth Factors and Future Trends
A number of factors, such as the growing number of patients being
treated in ICUs, NICUs, and emergency departments, and the increasing
adoption of technologically advanced biosensors and data analysis
software for developing next-generation blood gas analyzers are expected
to drive the growth of the blood gas analyzer market in the coming
years.
According to research report the Blood Gas and Electrolyte Analyzer Market
was estimated to be USD 506.9 Million in 2016, which would reach USD
636 Million by 2021, growing at a CAGR of 4.6% during 2016 to 2021.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=242278963
The other factors driving the growth of Blood Gas and Electrolyte
Analyzer Market include rising geriatric population and the subsequent
increase in the prevalence of chronic diseases, increasing adoption of
technologically advanced biosensors and data analysis software, growing
demand for technology integrated combined systems, and miniaturization
of POC blood gas analyzers.
North America is expected to account for the largest blood gas analyzer
market share in 2016, which is primarily attributed to the growing
prevalence of lifestyle diseases, increasing number of product
approvals, and rising government initiatives in this region. However,
the APAC Blood Gas Analyzers market is projected to witness a higher
growth during the forecast period due to the growing initiatives by
market players, increasing patient population base, and rising number of
partnerships and joint ventures.
The Blood Gas and Electrolyte Analyzer Market is segmented on the basis
of major product brands (i-STAT, epoc, GEM 3000, GEM 3500, GEM 4000,
ABL800, ABL80, ABL90, cobas b 221, cobas b 121, cobas b 123, RAPID
Series) in four major regional segments, namely, North America, Europe,
APAC, and Rest of the World. This report analyzes the market from both
value and volume perspectives. GEM 3000 is expected to account for the
largest share of the global blood gas analyzers market in 2016. This is
mainly because GEM 3000 delivers real-time system diagnostics, requires
low labor-intensive system calibration, and eliminates lengthy equipment
training and possible human errors. On the other hand, epoc (Alere) is
expected to be the fastest-growing brand in the coming years.
Request Free Report Sample Pages: http://www.marketsandmarkets.com/requestsample.asp?id=242278963
Leading players in Blood Gas and Electrolyte Analyzer Market are
focusing on the launch of new and improved products as their key growth
strategy. The major players in the global blood gas analyzers market are
Abbott Laboratories (U.S.), Alere, Inc. (U.S.), Instrumentation
Laboratory (U.S.), Radiometer (Denmark), Roche Diagnostics
(Switzerland), and Siemens Healthcare (Germany). Radiometer is expected
to command the largest share in this market with the launch of its
flagship products ABL800 and ABL90.
Comments
Post a Comment